Intellizence Business Signals of the Day

Jul 08
Jul 08
Jul 08
Jul 07
Jul 07
Jul 07
Jul 03

Annexon Raises $100 Million Financing

Annexon, a clinical-stage biopharmaceutical company that focuses on drugs for autoimmune and neurodegenerative disorders has raised $100 million in Series C financing. The funding will be used to accelerate their clinical and preclinical programs to combat classical complement-mediated diseases. The multiple product candidates in Annexon’s portfolio include: Annexon funding was... read more →
Jul 03
Jul 02
Jul 02